Here are the latest quarterly results of Divis Laboratories. For more details, see the Divis Laboratories financial fact sheet and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
3
Jun-20 |
3
Sep-20 |
3
Dec-20 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 12,564 | 11,399 | 14,456 | 13,905 | 13,762 | 17,100 | 17,138 | 16,565 | |
Other income | Rs m | 417 | 316 | 470 | 403 | 765 | 179 | 136 | 197 | |
Turnover | Rs m | 12,982 | 11,716 | 14,926 | 14,308 | 14,528 | 17,278 | 17,274 | 16,762 | |
Expenses | Rs m | 8,453 | 7,613 | 9,550 | 8,936 | 9,276 | 10,110 | 9,814 | 9,780 | |
Gross profit | Rs m | 4,111 | 3,786 | 4,906 | 4,969 | 4,486 | 6,990 | 7,324 | 6,785 | |
Depreciation | Rs m | 423 | 438 | 459 | 467 | 495 | 560 | 609 | 680 | |
Interest | Rs m | 1 | 3 | 38 | 16 | 4 | 2 | 1 | 2 | |
Profit before tax | Rs m | 4,104 | 3,661 | 4,879 | 4,889 | 4,752 | 6,607 | 6,850 | 6,300 | |
Tax | Rs m | 1,210 | 988 | 1,311 | 1,282 | 834 | 1,685 | 1,717 | 1,687 | |
Profit after tax | Rs m | 2,894 | 2,674 | 3,568 | 3,607 | 3,918 | 4,923 | 5,133 | 4,612 | |
Gross profit margin | % | 32.7 | 33.2 | 33.9 | 35.7 | 32.6 | 40.9 | 42.7 | 41.0 | |
Effective tax rate | % | 29.5 | 27.0 | 26.9 | 26.2 | 17.6 | 25.5 | 25.1 | 26.8 | |
Net profit margin | % | 23.0 | 23.5 | 24.7 | 25.9 | 28.5 | 28.8 | 30.0 | 27.8 | |
Diluted EPS | Rs | 10.9 | 10.1 | 13.4 | 13.6 | 14.8 | 18.5 | 19.3 | 17.4 | |
Diluted EPS (TTM) | Rs | 50.2 | 50.2 | 48.7 | 48.0 | 51.9 | 60.3 | 66.2 | 70.0 | |
![]() |
Read: Divis Laboratories 3QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: FRESENIUS KABI ONCO. DR. REDDYS LAB ALEMBIC IPCA LABS DISHMAN PHARMA
Compare DIVIS LABORATORIES With: FRESENIUS KABI ONCO. DR. REDDYS LAB ALEMBIC IPCA LABS DISHMAN PHARMA
Compare DIVIS LABORATORIES With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Indian share markets witnessed huge selling during closing hours on Friday and ended lower.
For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More